羊水淤泥抗生素治疗对早产的影响
这项回顾性队列研究纳入97例孕15-25周经阴道超声诊断羊水淤泥的单胎孕妇,比较口服抗生素治疗(51例)与未治疗(46例)的结局。结果显示抗生素治疗未降低37周前早产风险(调整OR 1.3,95%CI 0.77-1.9),也未改善其他产科、新生儿或病理指标。
要点
- 羊水淤泥患者37周前早产率高达49.4%,28周前早产率22.7%。
- 口服抗生素未降低37周前或28周前早产风险。
- 抗生素未改善绒毛膜羊膜炎、新生儿结局或淤泥超声消退率。
核心结论
- 羊水淤泥抗生素治疗与早产风险降低无关,也未改善其他产科、新生儿或病理变量。
- 研究提示羊水淤泥的 presumed 感染性质及不良结局不能被阿奇霉素治疗改善。
研究设计与样本
- 单中心回顾性队列研究,纳入2010-2017年孕15-25周经阴道超声诊断羊水淤泥的孕妇。
- 共97例符合标准,51例口服抗生素(46例阿奇霉素,5例莫西沙星),46例未治疗。
- 排除多胎、胎儿畸形、诊断前胎膜早破、活跃早产、前置胎盘和/或疑似植入。
主要发现
- 37周前早产总体发生率49.4%(48/97),28周前早产发生率22.7%(22/97)。
- 调整种族、BMI、吸烟、宫颈长度和早产史后,抗生素治疗未降低早产风险(调整OR 1.3,95%CI 0.77-1.9)。
临床怎么用
- 对于孕中期超声发现羊水淤泥的孕妇,不应常规给予口服抗生素以预防早产。
- 羊水淤泥患者早产风险高,需加强监测,但抗生素治疗不能改善结局。
局限性
- 回顾性队列设计,样本量较小(97例),可能存在选择偏倚和混杂。
- 抗生素方案不统一(阿奇霉素或莫西沙星),治疗依从性未报告。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Amniotic fluid sludge refers to the sonographic presence of echogenic, free-floating aggregates of debris located within the amniotic cavity near the internal cervical os of women with intact membranes. Clinically, it is independently associated with increased obstetric, infectious, and neonatal morbidity, including: short cervix, chorioamnionitis, and an increased risk of preterm birth. It is thought to be infectious in nature and has been described as an intrauterine bacterial biofilm. There is little evidence on the impact of treatment with antibiotics on outcome. OBJECTIVE: To determine whether outpatient antibiotics administered to women with amniotic fluid sludge would reduce preterm birth risk compared to no antibiotic treatment. MATERIALS AND METHODS: This was a retrospective cohort study of all patients diagnosed with amniotic fluid sludge by transvaginal sonography between 15 and 25 weeks' gestation in the outpatient ultrasound unit at a single academic center between 2010 and 2017. Patients were segregated according to whether they were treated with oral antibiotics at the time of diagnosis. Women with multiple gestation, fetal anomalies, preterm rupture of membranes prior to initial diagnosis of amniotic fluid sludge, and active preterm labor placenta previa and/or suspected accreta were excluded from analysis. Primary outcome of preterm birth at less than 37 weeks' gestation was compared by univariate and regression analysis to control for potential co-linear and/or confounding variables. Additional outcomes were compared by univariate analysis. RESULTS: A total of 181 patients were initially identified, and 97 patients met inclusion criteria. Of these patients, 51 were treated with oral antibiotics (46 azithromycin and 5 moxifloxacin), and 46 were not treated. The overall incidence of preterm birth at <37 weeks was 49.4 % (48 of 97) and preterm birth <28 weeks was 22.7% (22 of 97). There was no significant difference in preterm birth, either at <37 weeks (P = .47) or <28 weeks (P = .83) between the treated and untreated women. After adjusting for race, body mass index, tobacco use, cervical length, and preterm birth history, antibiotic treatment did not reduce the risk of preterm birth (adjusted odds ratio, 1.3; confidence interval, 0.77-1.9). No differences were seen in the incidence of preterm premature rupture of membranes (P = .94) or median latency from diagnosis to delivery (P = .47). Birthweight (P = .99), sepsis (P = .53), intraventricular hemorrhage (P = .95), and neonatal intensive care unit (NICU) admission (P = .08) were not affected by antibiotic treatment. Antibiotic treatment did not affect the incidence of either clinical or histologic chorioamnionitis (P = .92 and .14, respectively) or histologic stage 2-3 maternal or fetal inflammation (P = .94 and 0.58, respectively). Sonographic resolution of amniotic fluid sludge on first subsequent scan was seen in 34% of antibiotic-treated women and 43% of untreated women (P = .42). There was no difference in latency from diagnosis to delivery or mean gestational age at delivery according to whether sludge resolved or persisted at the first subsequent scan (P = .14 for each). CONCLUSION: Antibiotic treatment of amniotic fluid sludge is not associated with a reduction in premature birth. Likewise, antibiotic treatment of amniotic fluid sludge was not associated with improvement in other obstetric, neonatal, or pathologic variables. These findings suggest that the presumed infectious nature of sludge and subsequent adverse outcomes are not treated or improved by administration of azithromycin following midtrimester sonographic diagnosis.
引用
- Cuff RD, Carter E, Taam R, et al. Effect of Antibiotic Treatment of Amniotic Fluid Sludge. Am J Obstet Gynecol MFM. 2019. PMID: 33345987. doi:10.1016/j.ajogmf.2019.100073
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。